Neurological aspects of adult phenylketonuria
- 1 December 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 11 (6) , 679-688
- https://doi.org/10.1097/00019052-199812000-00012
Abstract
Phenylketonuria, an autosomal recessively transmitted disorder of amino acid metabolism, is caused by a deficiency of hepatic phenylalanine hydroxylase converting phenylalanine to tyrosine. Thus, phenylalanine accumulates to plasma levels exceeding 1200 μmol/l. Untreated phenylketonuria is characterized by microcephaly, epilepsy, severe mental retardation and, in some cases, progressive supranuclear motor disturbances. These symptoms can largely be prevented by the early start of a phenylalanine‐restricted diet. Neurological investigations of treated patients reveal only minor neurological signs, such as tremor or brisk deep tendon reflexes. Magnetic resonance imaging shows white matter abnormalities. However, in single patients, progressive neurological symptoms occurred. Thus, the long‐term prognosis of treated phenylketonuria is still under discussion. Curr Opin Neurol 11:679–688. © 1998 Lippincott Williams & WilkinsKeywords
This publication has 53 references indexed in Scilit:
- A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic PhenotypeAmerican Journal of Human Genetics, 1998
- Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino AcidsNeurochemical Research, 1998
- Effect of Hyperphenylalaninemia Chemically Induced onin VitroIncorporation of32P into Cytoskeletal Proteins from Cerebral Cortex of Developing RatsExperimental Neurology, 1997
- The PAH mutation analysis consortium database: update 1996Nucleic Acids Research, 1997
- Evidence for Central Nervous System Glial Cell Plasticity in PhenylketonuriaJournal of Neuropathology and Experimental Neurology, 1996
- Blood‐brain barrier transport of amino acids in healthy controls and in patients with phenylketonuriaJournal of Inherited Metabolic Disease, 1995
- Inhibition of Neutral Amino Acid Transport Across the Human Blood‐Brain Barrier by PhenylalanineJournal of Neurochemistry, 1995
- An animal model of early-treated PKUJournal of Neuroscience, 1994
- On a possible mechanism of abnormal brain development in experimental hyperphenylalaninemiaNeurochemistry International, 1987
- On a soluble system for studying light activation of rod outer segment cyclic GMP phosphodiesteraseNeurochemical Research, 1977